TOXBANK

ToxBank – Supporting Integrated Data Analysis and Servicing of Alternative Testing Methods in Toxicology

 Coordinatore ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI 

 Organization address address: Via Giuseppe La Masa 19
city: MILANO
postcode: 20156

contact info
Titolo: Dr.
Nome: Emilio
Cognome: Benfenati
Email: send email
Telefono: 390239000000
Fax: 390239000000

 Nazionalità Coordinatore Italy [IT]
 Totale costo 3˙129˙992 €
 EC contributo 1˙564˙996 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2010-Alternative-Testing
 Funding Scheme CP-IP
 Anno di inizio 2011
 Periodo (anno-mese-giorno) 2011-01-01   -   2015-12-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

 Organization address address: Via Giuseppe La Masa 19
city: MILANO
postcode: 20156

contact info
Titolo: Dr.
Nome: Emilio
Cognome: Benfenati
Email: send email
Telefono: 390239000000
Fax: 390239000000

IT (MILANO) coordinator 250˙316.00
2    DOUGLAS CONNECT GMBH

 Organization address address: BARMEGGENWEG 14
city: ZEININGEN
postcode: 4314

contact info
Titolo: Dr.
Nome: Barry
Cognome: Hardy
Email: send email
Telefono: +41 61 851 0170
Fax: +44 870 112 38 44

CH (ZEININGEN) participant 296˙300.00
3    IN SILICO TOXICOLOGY GMBH

 Organization address address: ALTKIRCHERSTRASSE 4
city: BASEL
postcode: 4054

contact info
Titolo: Dr.
Nome: Christoph
Cognome: Helma
Email: send email
Telefono: 41774339164
Fax: 497612000000

CH (BASEL) participant 202˙800.00
4    IDEACONSULT LIMITED LIABILITY COMPANY

 Organization address address: ANGEL KANCHEV 4
city: SOFIA
postcode: 1000

contact info
Titolo: Mr.
Nome: Vedrin
Cognome: Jeliazkov
Email: send email
Telefono: +359 887818654
Fax: +359 2 9526265

BG (SOFIA) participant 195˙920.00
5    "Leadscope, Inc."

 Organization address address: Dublin Road 1393
city: Columbus
postcode: 43215

contact info
Titolo: Dr.
Nome: Glenn
Cognome: Myatt
Email: send email
Telefono: 16146753731
Fax: 16146753732

US (Columbus) participant 194˙240.00
6    KAROLINSKA INSTITUTET

 Organization address address: Nobels Vag 5
city: STOCKHOLM
postcode: 17177

contact info
Titolo: Mr.
Nome: Per-Olof
Cognome: Larsson
Email: send email
Telefono: +46 8 524 875 00
Fax: +46 8 33 69 81

SE (STOCKHOLM) participant 150˙320.00
7    Department of Health

 Organization address address: Quarry House, Quarry Hill
city: Leeds
postcode: LS2 7UE

contact info
Titolo: Ms.
Nome: Amanda
Cognome: King
Email: send email
Telefono: +44 1707 641 000
Fax: +44 1707 641 050

UK (Leeds) participant 149˙660.00
8    PHARMATROPE

 Organization address address: CROTON ROAD 324
city: WAYNE
postcode: 19087

contact info
Titolo: Dr.
Nome: Jeffrey
Cognome: Wiseman
Email: send email
Telefono: 12677186318

US (WAYNE) participant 125˙440.00
9    DOUGLAS CONNECT

 Organization address address: Baermeggenweg 14
city: ZEININGEN
postcode: 4314

contact info
Titolo: Dr.
Nome: Barry
Cognome: Hardy
Email: send email
Telefono: +41 61 851 0170
Fax: +44 870 112 38 44

CH (ZEININGEN) participant 0.00
10    HEALTH PROTECTION AGENCY HPA

 Organization address address: Central Office - 7th Floor, Holborn Gate - High Holborn 330
city: LONDON
postcode: WC1V 7PP

contact info
Titolo: Ms.
Nome: Amanda
Cognome: King
Email: send email
Telefono: +44 1707 64 10 00
Fax: +44 1707 64 10 50

UK (LONDON) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

web    dose    gold    data    predictive    establishment    reference    systemic    human    tissues    whenever    toxbank    warehouse    toxicology    compounds    database    vitro    cells    cell    quality    selected    compound    banking    toxicity    resource    repeated    stem    lines    repository   

 Obiettivo del progetto (Objective)

'ToxBank establishes a dedicated web-based warehouse for toxicity data management and modelling, a ‘gold standards’ compound database and repository of selected test compounds, and a reference resource for cells, cell lines and tissues of relevance for in vitro systemic toxicity research carried out across the FP7 HEALTH.2010.4.2.9 Alternative Testing Strategies SEURAT program. The project develops infrastructure and service functions to create a sustainable predictive toxicology support resource going beyond the lifetime of the program. The following activities will be carried out: a) Establishment of a dedicated web-based data warehouse The ToxBank Data Warehouse will establish a centralised compilation of data for systemic toxicity. Data generated under the research program and additional public data will be uploaded and integrated whenever possible into computerised models capable of predicting repeated-dose toxicity. b) Establishment of a database of test compounds The ToxBank Gold Compound Database will provide a high quality information resource servicing the selection and use of test compounds. Chemicals in this database will be supported by high-quality repeated-dose toxicity in vivo and in vitro data, property data and, whenever available, human adverse event and epidemiological data. Selected test compounds for training or validation, and standard operating procedures for data quality control, processing and analyses will be provided. c) Establishment of a repository for the selected test compounds The ToxBank Chemical Repository will ensure the availability of test compounds to program researchers accompanied by sample preparation, handling and analytical quality control procedures. d) Setting up of a cell and tissue banking information resource for in vitro toxicity testing ToxBank will establish a banking information resource for access to qualified cells, cell lines (including stem cells and stem cell lines) and tissues and reference materials to be used for in vitro predictive toxicology research and testing activities.'

Introduzione (Teaser)

Toxicology studies are vital for ensuring the safety of a plethora of products destined for human use. An online database with toxicology-related information on compounds and resources should help minimise animal experimentation.

Altri progetti dello stesso programma (FP7-HEALTH)

PREVENTIT (2012)

ASSURED Point-of-Care Device for Syphilis and HIV in Pregnant Women and New Born

Read More  

EIS (2009)

Development of a European Implementation Score for measuring implementation of research into healthcare practice using vascular disease as an example

Read More  

UNCOVER (2011)

Evaluation and development of measures to uncover and overcome bias due to non-publication of clinical trials

Read More